|
| Gender | Male 32 (46%); female 38 (54%) |
| Mean age, years (range) | 39 (21–64) |
| Mean epilepsy duration, years (range) | 18 (1–57) |
| History of secondary generalized tonic-clonic seizures, (%) | 46 (66%) |
| Mean number of antiepileptic drugs tried (range) | 5 (1–10) |
| Mean follow-up, months (range) | 48 (24–87) |
| Resection site, (%) | Temporal, 54 (77%); extratemporal, 16 (23%) |
| Number of extraoperative invasive monitoring, (%) | 12 (17%) |
| Number of intraoperative electrocorticography, (%) | 41 (59%) |
| Ictal EEG, (%) | Concordant, 52 (74%); discordant, 16 (23%); inconclusive, 2 (3%) |
| Interictal EEG, (%) | Concordant, 37 (53%); discordant, 25 (36%); normal, 8 (11%) |
| MRI, (%) | Abnormal 53 (76%); normal 17 (24%) |
| Number of patients who had Wada test, (%) | 52 (74%) |
| Wada memory lateralization, (%) | Concordant 44 (85%); discordant 8 (15%) |
| Pathology, (%) | Mesial temporal sclerosis or gliosis 45 (64%); benign tumor 7 (10%); vascular lesion 4 (4%); other 7 (10%); normal 7 (10%) |
|
